Bradykinin-induced coronary chemoreflex in the dog.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D001920:Bradykinin / Q000008:administration & dosage / Q000494:pharmacology*; D002628:Chemoreceptor Cells / Q000187:drug effects*; D003331:Coronary Vessels / Q000187:drug effects*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D007269:Injections, Intra-Arterial; D008297:Male; D009388:Neostigmine / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology; D012018:Reflex / Q000187:drug effects*; D012119:Respiration / Q000187:drug effects; D013997:Time Factors; D014628:Vagotomy; D014630:Vagus Nerve / Q000502:physiology; D014702:Veratrine / Q000494:pharmacology
D010455:Peptides; D009388:Neostigmine; D001285:Atropine; D014702:Veratrine; D001920:Bradykinin